Evidence map›Paper›PMID 24283944›Full record

ArticleMolecular microbiology2014

A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A.

Iyarit Thaipisuttikul, Lauren E Hittle, Ramesh Chandra, Daniel Zangari, Charneal L Dixon, Teresa A Garrett, David A Rasko, Nandini Dasgupta, Samuel M Moskowitz, Lars Malmström and 4 more

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Engineering low-endotoxin lipid A in a double auxotrophFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. A critical role forProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. LpxR and PagL expression in live attenuated auxotrophicFrontiers in cellular and infection microbiology · 2025
    Article
  10. American journal of respiratory cell and molecular biology · 2024
    Article
  11. DivergentmBio · 2024
    Article
  12. Unravelling the mechanisms causing murepavadin resistance inFrontiers in cellular and infection microbiology · 2024
    Article
  13. Article
  14. Article
  15. A periplasmic phospholipase that maintains outer membrane lipid asymmetry inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Iyarit ThaipisuttikulDepartment of Microbial Pathogenesis, University of Maryland, School of Dentistry, University of Maryland, Baltimore, MD, 21201, USA; Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkoknoi, Bangkok, 10700, Thailand.
Lauren E Hittle
Ramesh Chandra
Daniel Zangari
Charneal L Dixon
Teresa A Garrett
David A Rasko
Nandini Dasgupta
Samuel M Moskowitz
Lars Malmström
David R Goodlett
Samuel I Miller
Russell E Bishop
Robert K Ernst
University of Maryland, Baltimore · USMcMaster University · CAMassachusetts General Hospital · USÉcole Polytechnique Fédérale de Lausanne · CHMahidol University · THUniversity of Washington · USVassar College · US

Funding

ROLE OF THE PHOP REGULON IN SALMONELLA VIRULENCER01AI030479 · NIAID · UNIVERSITY OF WASHINGTON · PI MILLER, SAMUEL I · 1991 to 2014
$5.3M
Pseudomonas aeruginosa lipid AR01AI047938 · NIAID · UNIVERSITY OF WASHINGTON · PI ERNST, ROBERT K · 2001 to 2010
$3.4M
Polymyxin-resistant Pseudomonas in CF Lung InfectionR01AI067653 · NIAID · UNIVERSITY OF WASHINGTON · PI MOSKOWITZ, SAMUEL M · 2007 to 2010
$2.5M
CIHR MOP-125979NIAID NIH HHS R01 AI030479NIAID NIH HHS R01AI030479NIAID NIH HHS R01 AI047938NIAID NIH HHS R01AI047938NIAID NIH HHS R01 AI067653NIAID NIH HHS R01AI067653
6 · The paper itself

Abstract

Strains of Pseudomonas aeruginosa (PA) isolated from the airways of cystic fibrosis patients constitutively add palmitate to lipid A, the membrane anchor of lipopolysaccharide. The PhoPQ regulated enzyme PagP is responsible for the transfer of palmitate from outer membrane phospholipids to lipid A. This enzyme had previously been identified in many pathogenic Gram-negative bacteria, but in PA had remained elusive, despite abundant evidence that its lipid A contains palmitate. Using a combined genetic and biochemical approach, we identified PA1343 as the PA gene encoding PagP. Although PA1343 lacks obvious primary structural similarity with known PagP enzymes, the β-barrel tertiary structure with an interior hydrocarbon ruler appears to be conserved. PA PagP transfers palmitate to the 3' position of lipid A, in contrast to the 2 position seen with the enterobacterial PagP. Palmitoylated PA lipid A alters host innate immune responses, including increased resistance to some antimicrobial peptides and an elevated pro-inflammatory response, consistent with the synthesis of a hexa-acylated structure preferentially recognized by the TLR4/MD2 complex. Palmitoylation commonly confers resistance to cationic antimicrobial peptides, however, increased cytokine production resulting in inflammation is not seen with other palmitoylated lipid A, indicating a unique role for this modification in PA pathogenesis.

Indexed as

Acidic GlycosphingolipidsAcyltransferasesAmino Acid MotifsAmino Acid SequenceAntimicrobial Cationic PeptidesBacterial ProteinsCatalytic DomainCystic FibrosisCytokinesDrug Resistance, BacterialEscherichia coli ProteinsHumansImmunity, InnateLipid ALipoylationModels, MolecularAcidic GlycosphingolipidsAcyltransferasesAntimicrobial Cationic PeptidesBacterial ProteinsCytokinesEscherichia coli ProteinsLipid ALipid IVPagP protein, E coliPalmitatesPolymyxin B

Identifiers

PMID24283944
PMCPMC3935289
OpenAlexW2104336577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.